The citation reads:
“Professor Stephen O’Rahilly has conducted research which changed the way we think about obesity and diabetes. He has ensured that his research impacts directly on patients, by establishing a national specialist service for those with severe insulin resistance. He was the first person to show that a change in genetic factors can lead to serious obesity and the first to cure the life-threatening obesity of congenital leptin deficiency. He has received a series of international awards.”
Professor O’Rahilly is Co-Director of the Wellcome Trust-MRC IMS. He is also the Principal Investigator on an MRC Programme Grant focused on Molecular and Pathophysiological Mechanisms in Obesity. Last week it was announced that he would also be the director of the new MRC Metabolic Diseases Unit, set up as part of a £24 million grant by the Wellcome Trust and the MRC to research the causes and health consequences of obesity.